Abstract:Background Current approaches fail to separate patients at high versus low risk for ventricular arrhythmias owing to overreliance on a snapshot left ventricular ejection fraction measure. We used statistical machine learning to identify important cardiac imaging and time‐varying risk predictors. Methods and Results Three hundred eighty‐two cardiomyopathy patients (left ventricular ejection fraction ≤35%) underwent cardiac magnetic resonance before primary prevention implantable cardioverter defibrillator insertion. The primary end point was appropriate implantable cardioverter defibrillator discharge or sudden death. Patient characteristics; serum biomarkers of inflammation, neurohormonal status, and injury; and cardiac magnetic resonance‐measured left ventricle and left atrial indices and myocardial scar burden were assessed at baseline. Time‐varying covariates comprised interval heart failure hospitalizations and left ventricular ejection fractions. A random forest statistical method for survival, longitudinal, and multivariable outcomes incorporating baseline and time‐varying variables was compared with (1) Seattle Heart Failure model scores and (2) random forest survival and Cox regression models incorporating baseline characteristics with and without imaging variables. Age averaged 57±13 years with 28% women, 66% white, 51% ischemic, and follow‐up time of 5.9±2.3 years. The primary end point (n=75) occurred at 3.3±2.4 years. Random forest statistical method for survival, longitudinal, and multivariable outcomes with baseline and time‐varying predictors had the highest area under the receiver operating curve, median 0.88 (95% CI, 0.75‐0.96). Top predictors comprised heart failure hospitalization, left ventricle scar, left ventricle and left atrial volumes, left atrial function, and interleukin‐6 level; heart failure accounted for 67% of the variation explained by the prediction, imaging 27%, and interleukin‐6 2%. Serial left ventricular ejection fraction was not a significant predictor. Conclusions Hospitalization for heart failure and baseline cardiac metrics substantially improve ventricular arrhythmic risk prediction. Nonstandard Abbreviations and Acronyms LGE late gadolinium enhancement RF‐SLAM random forest survival, longitudinal and multivariate outcomes SCD sudden cardiac death SI signal intensity Clinical Perspective What Is New? In primary prevention implanted cardioverter defibrillator (ICD) recipients, an interim hospitalization for heart failure identified a group at high risk for subsequent ventricular arrhythmia defined as an appropriate ICD shock. Among ICD recipients without heart failure hospitalizations, baseline cardiac magnetic resonance imaging metrics (specifically, left ventricle heterogeneous gray and total scar, left ventricle and left atrial volumes, and left atrial total emptying fraction) as well as serum interleukin‐6 levels were the strongest predictors of subsequent appropriate ICD shock; serial left ventricle ejection fraction did not provide additional prognostic value for the arrhythmic outcome. Machine learning statistical methods may improve risk score development by accounting for complex and dynamic interactions among risk variables and temporally varying risk. What Are the Clinical Implications? The combination of clinical heart failure course, baseline cardiac magnetic resonance imaging metrics, and levels of the inflammatory biomarker interleukin‐6 can most accurately stratify subsequent high versus low ventricular arrhythmic risk and may be useful for decision‐making as primary prevention ICD recipients approach elective generator change. Identifying patients most at risk for ventricular arrhythmias and sudden cardiac death (SCD) remains a clinical challenge. 1 Current guidelines directing the use of primary prevention implanted cardioverter defibrillator (ICDs) rely on a reduced left ventricular ejection fraction (LVEF), which has low predictive efficiency. 1 Estimated annualized rates of appropriat -Abstract Truncated-

Predictors of Pace-Terminable Rhythms in Patients with Subcutaneous Implantable Cardioverter-Defibrillators

Clinical evaluation of pacemaker automatic capture management and atrioventricular interval extension algorithm.

Competing risks of monomorphic vs. non-monomorphic ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) study

Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring

Risk stratification for ventricular tachyarrhythmia in patients with nonischemic cardiomyopathy

First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial

Active Arrhythmia Pattern: A Novel Predictor of ICD Shocks-A Subanalysis From the PARTITA Study

Risk Factors for Arrhythmic Death, Overall Mortality, and Ventricular Tachyarrhythmias Requiring Shock After Myocardial Infarction

Predictors of ventricular arrhythmias after cardiac resynchronization therapy defibrillator

Risk of Malignant Ventricular Arrhythmias in Patients with Mild to Moderately Reduced Ejection Fraction Following Permanent Pacemaker Implantation

No Association Between T-peak to T-end Interval on the Resting ECG and Long-Term Incidence of Ventricular Arrhythmias Triggering ICD Interventions

Predictors of appropriate ICD discharges and the additive role of late gadolinium enhancement in hypertrophic cardiomyopathy

Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial

B-PO04-154 TIME OF DAY OF VENTRICULAR TACHYARRHYTHMIAS AFTER MYOCARDIAL INFARCTION: RESULTS FROM THE VEST TRIAL

Prophylactic ICD Survival Benefit Prediction: Review and Comparison between Main Scores

Microvolt T-wave alternans and autonomic nervous system parameters can be helpful in the identification of low-arrhythmic risk patients with ischemic left ventricular systolic dysfunction

Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy.

Combining noninvasive risk stratification parameters improves the prediction of mortality and appropriate ICD shocks

The occurrence characteristics and optimal management of inappropriate shocks in patients with implantable cardioverter defibrillator

Retrospective Analysis of the Appropriate and Inappropriate Shock Characteristics in 134 Patients with Implantable Cardioverter-Defibrillator

Extravascular Implantable Cardioverter-Defibrillator Sensing and Detection in a Large Global Population